Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1909 of 5804
-
Diabetes drug trial halted: could BMF-219 have boosted insulin?
Disease control TerminatedPhase 2 Trial of BMF-219 in Participants with Type 1 Diabetes Mellitus.
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could 2 days of antibiotics be enough for deadly Flesh-Eating infections?
Disease control Recruiting nowNecrotizing soft tissue infection (NSTI) is a devastating disease that results in a high rate of in-hospital complications and despite advances in critical care, wound care, and early intervention, NSTI continues to be associated with a mortality rate of nearly 30%. The antibioti…
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Italian study tracks new antibody drugs for lymphoma patients
Knowledge-focused Recruiting nowThis is a prospective, observational cohort study to evaluate the clinical impact of novel Monoclonal AntiBodies (MAB) in B-cell Non-Hodgkin Lymphoma (NHL) in Italian clinical practice.
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New breathalyzer aims to sniff out COVID-19 in seconds
Diagnosis Recruiting nowThe primary objective of this effort will be to optimize and operationalize innovative passive surveillance systems and in parallel, the effort will identify, evaluate, and transition groundbreaking new technologies in diagnostics for operationalization. To meet the objective an…
Sponsor: The Geneva Foundation • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
New scan could sharpen targeting of breast cancer brain spread
Diagnosis Recruiting nowThe goal of this interventional study is to optimize the protocol of FES PET/CT in Estrogen Receptor positive Breast cancer patients with Brain metastases. Patients will undergo MRI of the brain and FDG PET/CT brain as part of standard of care for radiation treatment planning. An…
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Exercise program aims to help anxious smokers kick the habit
Symptom relief Recruiting nowAnxiety sensitivity, reflecting the fear of bodily sensations, is a risk factor for the maintenance and relapse of smoking. This study is designed to address the question - is a smoking cessation intervention personalized to high anxiety sensitive smokers and adapted for implemen…
Phase: PHASE3 • Sponsor: Jasper A. Smits • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
10,000 pregnant women join study to uncover virus risks
Knowledge-focused Recruiting nowThis study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medical College Hospital, Nagpur. The Hospital provides primary, secondary, and terti…
Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New painkiller aims to ease suffering after abdominal surgery
Symptom relief CompletedPrimary Objective: To explore the analgesic efficacy of YZJ-4729 compared with placebo in patients with acute postoperative pain following abdominal surgery. Secondary Objective: To explore the analgesic efficacy and safety of YZJ-4729 compared with placebo and morphine in patie…
Phase: PHASE2 • Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Triple-Drug cocktail for septic shock shows promise in small trial
Disease control CompletedThe goal of this prospective randomized controlled trial is to compare the effects of classic stepwise vs. early balanced multimodal vasopressor strategies in septic shock.
Phase: PHASE2, PHASE3 • Sponsor: University Medical Centre Maribor • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can lupus patients safely get the shingles vaccine? new trial aims to find out
Disease control Recruiting nowThis randomized, double-blind, placebo-controlled, non-inferiority crossover study will evaluate the Herpes Zoster Sunbit (HZ/su) vaccine in SLE patients in order to evaluate safety and immunogenicity in patients with variable baseline clinical activities, ages and immunosuppress…
Phase: PHASE4 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Pill power: oral antibiotic could replace IV for tough UTIs
Disease control CompletedThe primary purpose of this study is to assess the efficacy of oral TBP-PI-HBr as compared with intravenous (IV) imipenem-cilastatin with respect to the overall response (combined clinical cure plus microbiological eradication) at the Test-of-Cure (TOC) visit in hospitalized adul…
Phase: PHASE3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New ointment could treat larger patches of Sun-Damaged skin
Disease control CompletedThe purpose of the study is to evaluate the efficacy and safety of tirbanibulin 10 milligrams per gram (mg/g) ointment when applied to a treatment field (TF) larger than 25 square centimeters (cm\^2) and up to 100 cm\^2 in adult participants with actinic keratosis (AK).
Phase: PHASE3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New depression pill shows promise in Late-Stage trial
Symptom relief CompletedThis randomized, double-blind, placebo-controlled, multicenter study will evaluate the effects of NMRA-335140 (formerly BTRX-335140) on symptoms of depression in participants with Major Depressive Disorder (MDD). The study design consists of a Screening Period (up to 35 days), an…
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Massive global study tracks Durvalumab's Real-World impact on liver cancers
Knowledge-focused Recruiting nowGiven the number of anticipated durvalumab-based treatment launches in the hepatobiliary cancer space over the next 3 years, there is a need to capture contemporary real-world data across these indications. LIVER-R is a multicountry, multicenter, observational study of patients w…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
One shot to stop clots? new drug tested in knee surgery patients
Prevention OngoingThis study was to compare the study drug KN060 to enoxaparin, for the prevention of blood clotting and safety in patients undergoing total knee arthroplasty (TKA).
Phase: PHASE2 • Sponsor: Suzhou Alphamab Co., Ltd. • Aim: Prevention
Last updated Jun 26, 2026 18:15 UTC
-
New depression pill shows promise in Late-Stage trial
Symptom relief CompletedThis is a randomized, double-blind, placebo-controlled, multicenter study to evaluate the effects of NMRA-335140 (formerly BTRX-335140) on symptoms of depression in participants with Major Depressive Disorder (MDD). The study design consists of a Screening Period (up to 28 days),…
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Can a higher dose of cabozantinib outsmart advanced kidney cancer?
Disease control Recruiting nowThe goal of this clinical trial is to learn about the effects of a higher dose of ncabozantinib in patients with advanced renal cell carcinoma who have progressed on or after receiving cabozantinib treatment.
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a monthly ring replace the pill? new study tests Hormone-Free contraceptive
Disease control Recruiting nowThis will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.
Phase: NA • Sponsor: Daré Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can heating milk and egg make them safe for kids with EoE?
Disease control Recruiting nowThe objective of the study is to study whether the introduction of heated food products (more specifically heated hen's egg and/or cow's milk) in children with EoE would be possible without re-occurrence of the eosinophilic inflammation, while the intake of less heated products m…
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Texts and EHR nudges aim to close the breast cancer screening gap
Prevention CompletedIn this study, personalized nudges to clinicians and patients will be evaluated to help increase breast cancer screening rates in accordance with USPSTF guidelines among women with a primary care visit, with a particular emphasis on those at high risk for non-completion of cancer…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC